Geriatrics

Analysis of the Framingham Heart Study indicates the rate of ICH in older patients has been on the rise and suggests anticoagulant use could have contributed to this increase.

A new analysis examines impact of treatment adherence in more than 1.2 million patients.

The tau tracer can support a pathological diagnosis of Alzheimer disease by identifying the underlying presence of NFTs at the B3 level.

The new technology has applications for diagnosis and recruitment for disease-modifying trials.

The findings can lead physicians to stop prescribing the drug.

Investigators estimate 40-50% of proton pump inhibitor users are using inappropriately.

Social isolation could increase risk for cardiovascular events by 40%, according to new research presented at EAN 2020 Virtual Congress.

Investigators discover Veterans are not at a higher risk of developing dementia than civilians.

New research suggests the presence of either condition can wreak havoc on an older adult's ability for movement, self-care, and household activities.

Despite patients being off treatment for an average of 23 months, patients treated with Eisai’s BAN2401 remained amyloid PET negative in an open-label extension preliminary analysis.

A new AI model from the New York Eye and Ear Infirmary of Mount Sinai boasts 99.2% accuracy for diagnosing intermediate or late AMD.

Discussing the results of a study examining impact of vitamin D and homotaurine supplementation on early to intermediate age-related macular degeneration.

Rishi Singh, MD, discusses differences in disease activity noted among nAMD patients enrolled in the pivotal HAWK and HARRIER trials.

Discussing the impact of high-intensity statin therapy on patients with dry AMD with a study investigator from Byers Eye Institute.

Discussing the latest data from Adverum Biotechnologies related to ADVM-022 and the ongoing phase 1 OPTIC trial with the trial's principal investigator.

Discussing how end of study results from the phase 2 LADDER trial inform clinicians on the use of PDS with ranibizumab.

A new analysis of STAIRWAY from ARVO 2020 is shedding additional light on the effects of faricimab use.

Older patients with worse sleep patterns who are treated for depression need further clinical attention.

The findings can lead to new interventions to prevent the development of diabetes in older men.

Response does not favor more or less baseline symptom severity according to a new study.

Since 2005, opioid use has increased amongst older dementia patients.

Higher dosages of chloroquine can lead to safety hazards.

A majority of patients hospitalized have at least 1 underlying condition and are older.

New research from an NIH-funded study suggest 0.004 mg bevacizumab could be an effective treatment for type 1 retinopathy of prematurity.

An analysis from the Women's Health Initiative has uncovered a potential link between visual impairment and risk of incident dementia.